Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

GEO ENERGY RESOURCES LIMITED (RE4)

  • Business News
  • Aug. 07, 2026, 12:30 UTC
  • 0
  • 1 comments

Mandatory Cash Dividend/ Distribution:

Market reaction Comment Full text

DRAGANFLY INC. (DPRO)

  • Business News
  • Aug. 07, 2026, 12:30 UTC
  • 0
  • 1 comments

Draganfly to Host Shareholder Update Call on August 10, 2026

Market reaction Comment Full text

RUNWAY GROWTH FINANCE CORP. (RWAY)

  • Business News
  • Aug. 07, 2026, 12:30 UTC
  • 0
  • 1 comments

Runway Growth Capital Appoints Michael Rovner as Co-Chief Executive Officer and Co-Chief Investment Officer

Market reaction Comment Full text

PRENETICS GLOBAL LTD (PRE)

  • Business News
  • Aug. 07, 2026, 12:30 UTC
  • 0
  • 1 comments

Prenetics to Report Q2 2026 Financial Results on August 18, 2026, Live-Stream Earnings Event on Stocktwits, and Announces Upcoming Conference Participation

Market reaction Comment Full text

MICWARE CO., LTD. (MWC)

  • Business News
  • Aug. 07, 2026, 12:30 UTC
  • 0
  • 1 comments

ミックウェア、Alphaterra Advisoryによる新たなエクイティ・リサーチレポートの発行を発表

Market reaction Comment Full text

MICWARE CO., LTD. (MWC)

  • Business News
  • Aug. 07, 2026, 12:30 UTC
  • 0
  • 1 comments

Micware Co., Ltd. Announces New Equity Research Report from Alphaterra Advisory

Market reaction Comment Full text

BATH & BODY WORKS, INC. (BBWI)

  • Business News
  • Aug. 07, 2026, 12:30 UTC
  • 1
  • 1 comments

Bath & Body Works Declares Cash Dividend

Market reaction Comment Full text

SEALSQ CORP (LAES)

  • Business News
  • Aug. 07, 2026, 12:30 UTC
  • 0
  • 1 comments

SEALSQs SEALQuantum Sovereign Quantum Vertical Stack Interconnects Its Growing Ecosystem as $200 Million SEALQuantum.com Initiative Enters Second Phase of Deployment in September

Market reaction Comment Full text

NEUROCRINE BIOSCIENCES INC (NBIX)

  • Business News
  • Aug. 07, 2026, 12:30 UTC
  • 1
  • 1 comments

Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating NBIP-1968, a GLP-1/GIP/Glucagon Receptor Triple Agonist

Market reaction Comment Full text

GRANITE CONSTRUCTION INC (GVA)

  • Business News
  • Aug. 07, 2026, 12:30 UTC
  • 0
  • 1 comments

Granite Appoints George L. Nash, Jr. to Board of Directors

Market reaction Comment Full text
  • Previous
  • 538
  • 539
  • 540
  • 541
  • 542
  • Next

Search

News categories

  • Technical Exchange News(14281)
  • Event(6229)
  • SEC News(370837)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(227295)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin